Utah Medical Products stock analysis
Utah Medical Products (UTM) Stock Price & Analysis
UTM Stock Chart & Stats
- Day’s Range
- EUR 65.50 - EUR 65.50
- 52-Week Range
- EUR 45.60 - EUR 65.50
- Previous Close
- EUR 64.50
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 190.30M
- Enterprise Value
- EUR 150.48M
- Total Cash (Recent Filing)
- EUR 85.20M
- Total Debt (Recent Filing)
- EUR 180.00K
- Price to Earnings (P/E)
- 21.5
- Beta
- 0.41
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.58%
Bulls Say, Bears Say
Bulls Say
Strong Profitability
UTMD’s high gross and net margins indicate meaningful profitability in its regulated medical-device portfolio. Maintaining this margin quality supports internal funding for product development, sales infrastructure, and acquisitions while providing resilience if procedure volumes fluctuate.
High-Quality Cash Conversion
Cash generation closely tracks reported earnings, showing that UTMD’s profitability converts efficiently into funds available for reinvestment, acquisitions, dividends, or balance-sheet strengthening. This supports financial self-reliance and reduces dependence on external financing for future initiatives.
Conservative Balance Sheet
A near-debt-free capital structure limits solvency and refinancing exposure, leaving UTMD substantial flexibility to withstand operating pressure or pursue targeted growth. The conservative balance sheet also allows cash-funded strategic investments without materially increasing financial risk.
Bears Say
Persistent Revenue Contraction
Repeated revenue declines point to weakening demand or market momentum across UTMD’s served product areas rather than a single quarterly fluctuation. Continued contraction could reduce operating leverage, constrain investment capacity, and make stable earnings increasingly dependent on margins.
Shrinking Free Cash Flow
Although UTMD still produces positive cash flow, the downward trend reduces the resources available for acquisitions, shareholder returns, and product investment. If the contraction persists alongside weaker revenue, it could gradually erode the company’s ability to fund growth internally.
Deteriorating Return Profile
Lower margins and declining return on equity suggest that the business is generating less economic output from its operations and capital base than in earlier years. Persistent deterioration would weaken earnings quality over time, even though absolute profitability remains strong.
Utah Medical Products News
UTM FAQ
What was Utah Medical Products’s price range in the past 12 months?
What is Utah Medical Products’s market cap?
When is Utah Medical Products’s upcoming earnings report date?
How were Utah Medical Products’s earnings last quarter?
Is Utah Medical Products overvalued?
Does Utah Medical Products pay dividends?
What is Utah Medical Products’s EPS estimate?
How many shares outstanding does Utah Medical Products have?
What happened to Utah Medical Products’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Utah Medical Products?
What is the TipRanks Smart Score and how is it calculated?
Utah Medical Products Stock Smart Score
Company Description
Utah Medical Products
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Kevin L. Cornwell
- Employees
- 146
- Website
- www.utahmed.com
- Address
- 7043 South 300 West, Midvale, UT, 84047-1048, US
Utah Medical Products (UTM) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 1 | 4 |
| Technical Analysis | 4 | 1 | 4 |
| Moving Averages | 12 | 0 | 0 |
